RT Journal Article
SR Electronic
T1 Epidemic prevention and control measures in China significantly curbed the epidemic of COVID-19 and influenza
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.09.20058859
DO 10.1101/2020.04.09.20058859
A1 Kong, Xiang-Sha
A1 Liu, Feng
A1 Wang, Hai-Bo
A1 Yang, Rui-Feng
A1 Chen, Dong-Bo
A1 Wang, Xiao-Xiao
A1 Lu, Feng-Min
A1 Rao, Hui-Ying
A1 Chen, Hong-Song
YR 2020
UL http://medrxiv.org/content/early/2020/04/14/2020.04.09.20058859.abstract
AB At the end of 2019, an outbreak of unknown pathogen pneumonia occurred in China, then it was named corona virus disease 2019 (COVID-19). With the rapid spread of COVID-19, a series of strict prevention and control measures were implemented to cut the spread of the epidemic. Influenza as a respiratory tract infection disease as COVID-19 might also be controlled. To assess the effects, we used the total passenger numbers sent in mainland China from 2018 to 2020 and the daily number of railway passenger (DNRP) flow in 2020 during Spring Festival travel rush to reflect the population movement and further to analyze newly and cumulative confirmed COVID-19 and influenza. We found that with implementing the series measures on COVID-19, not only COVID-19, but also influenza mitigated in China. The prevention and control measures for COVID-19 might be used in controlling respiratory tract diseases, and reducing the national health economic burden. When other countries issue measures on COVID-19 and influenza, they should consider adopting more aggressive epidemic prevention and control strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding in the work presented.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are available from the corresponding author upon request.